Bumetanide Injection Shortage

• • Bumetanide injection, Novadoz, 0.25 mg/mL, 10 mL vial, 10 count, NDC 72205-0102-07 - discontinued
  • Bumetanide injection, Novadoz, 0.25 mg/mL, 4 mL vial, 10 count, NDC 72205-0101-07 - discontinued

• • Fresenius Kabi has bumetanide injection available.
  • Glenmark has bumetanide injection available.
  • Hikma did not provide a reason for the shortage.
  • Novadoz has discontinued bumetanide.
  • Pfizer discontinued bumetanide injection in August 2022.
  • Sagent has bumetanide injection available.

• • Bumetanide injection, Fresenius Kabi, 0.25 mg/mL, 10 mL vial, 10 count, NDC 65219-0570-10
  • Bumetanide injection, Fresenius Kabi, 0.25 mg/mL, 4 mL vial, 10 count, NDC 65219-0570-04
  • Bumetanide injection, Glenmark, 0.25 mg/mL, 10 mL vial, 10 count, NDC 68462-0470-54
  • Bumetanide injection, Glenmark, 0.25 mg/mL, 4 mL vial, 10 count, NDC 68462-0469-54
  • Bumetanide injection, Hikma, 0.25 mg/mL, 10 mL vial, 10 count, NDC 00641-6007-10
  • Bumetanide injection, Hikma, 0.25 mg/mL, 4 mL vial, 10 count, NDC 00641-6008-10
  • Bumetanide injection, Sagent, 0.25 mg/mL, 10 mL vial, 10 count, NDC 25021-0321-10
  • Bumetanide injection, Sagent, 0.25 mg/mL, 4 mL vial, 10 count, NDC 25021-0321-04

Estimated Resupply Dates

• • All marketed presentations are available.